StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.22−0.16 (-11.59%)

Close on Nov 17, 2026Market cap $27.65MP/E –Yield –

BioHarvest Sciences cash

Cash and short-term investments held at the end of each period.

BioHarvest Sciences's cash was $23.03M at Dec 31, 2025. For fiscal 2025 it was $23.03M, up 863.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$23.03M+863.4%
FY2024Dec 31, 2024$2.39M-55.4%
FY2023Dec 31, 2023$5.36M+208.5%
FY2022Dec 31, 2022$1.74M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$23.03M–
Q4 FY2024Dec 31, 2024$2.39M–
Q4 FY2023Dec 31, 2023$5.36M–
Q4 FY2022Dec 31, 2022$1.74M–

More BioHarvest Sciences figures

See a number that looks wrong?